CZ265896A3 - Tryptase inhibitor, its use and pharmaceutical compositions containing thereof - Google Patents

Tryptase inhibitor, its use and pharmaceutical compositions containing thereof Download PDF

Info

Publication number
CZ265896A3
CZ265896A3 CZ962658A CZ265896A CZ265896A3 CZ 265896 A3 CZ265896 A3 CZ 265896A3 CZ 962658 A CZ962658 A CZ 962658A CZ 265896 A CZ265896 A CZ 265896A CZ 265896 A3 CZ265896 A3 CZ 265896A3
Authority
CZ
Czechia
Prior art keywords
virus
alp
viral
tryptase
clara
Prior art date
Application number
CZ962658A
Other languages
Czech (cs)
English (en)
Inventor
Hiroshi Kido
Masato Tashiro
Shozaburo Sekido
Original Assignee
Tokyo Tanabe Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Tanabe Co filed Critical Tokyo Tanabe Co
Publication of CZ265896A3 publication Critical patent/CZ265896A3/cs

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/57Protease inhibitors from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CZ962658A 1994-03-23 1995-03-20 Tryptase inhibitor, its use and pharmaceutical compositions containing thereof CZ265896A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5223794 1994-03-23

Publications (1)

Publication Number Publication Date
CZ265896A3 true CZ265896A3 (en) 1997-06-11

Family

ID=12909121

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ962658A CZ265896A3 (en) 1994-03-23 1995-03-20 Tryptase inhibitor, its use and pharmaceutical compositions containing thereof

Country Status (16)

Country Link
US (1) US5900401A (enExample)
EP (1) EP0804930A1 (enExample)
KR (1) KR970701561A (enExample)
CN (1) CN1144488A (enExample)
AU (1) AU689559B2 (enExample)
BG (1) BG100835A (enExample)
BR (1) BR9507165A (enExample)
CA (1) CA2186111A1 (enExample)
CZ (1) CZ265896A3 (enExample)
FI (1) FI963753L (enExample)
HU (1) HUT75660A (enExample)
NZ (1) NZ282488A (enExample)
PL (1) PL316444A1 (enExample)
RO (1) RO113431B1 (enExample)
SK (1) SK119896A3 (enExample)
WO (1) WO1995025539A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1021405B1 (en) * 1997-10-07 2002-09-25 Boehringer Ingelheim (Canada) Ltd. Azetidinone derivatives for the treatment of hcmv infections
DE69810651T2 (de) * 1997-10-07 2003-08-21 Boehringer Ingelheim (Canada) Ltd., Laval Azetidinonderivate zur behandlung von hcmv entzündungen
EP1023265B1 (en) * 1997-10-07 2003-01-15 Boehringer Ingelheim (Canada) Ltd. Azetidinone derivatives for the treatment of hcmv infections
US8679462B2 (en) * 2002-04-11 2014-03-25 Saeed Rezakhany Methods of preventing respiratory infections
US20230113110A1 (en) * 2020-03-09 2023-04-13 Organes,Tissus: Regeneration, Reparation, Remplacement Composition for the treatment of lesions of the respiratory system

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986000077A1 (en) * 1984-06-14 1986-01-03 Cortech, Inc. Human leukocyte elastase inhibitors prepared from pyogenic bacteria and methods for their purification
JPS62501291A (ja) * 1984-12-06 1987-05-21 サイナ−ゲン バイオロジカルズ,インコ−ポレ−テツド 精製セリンプロテアーゼインヒビターおよびこれを含有する医薬組成物
AU590238B2 (en) * 1984-12-06 1989-11-02 Amgen, Inc. Recombinant methods for production of serine protease inhibitors and dna sequences useful for same
US4760130A (en) * 1984-12-06 1988-07-26 Synergen Biologicals, Inc. Serine protease inhibitors and methods for isolation of same
EP0205555B2 (en) * 1984-12-06 2002-04-10 Amgen Inc. Serine protease inhibitors and methods for isolation of same
DE3600571A1 (de) * 1986-01-10 1987-08-06 Gruenenthal Gmbh Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel
US5290762A (en) * 1986-12-24 1994-03-01 John Lezdey Treatment of inflammation
CA1340877C (en) * 1987-12-28 2000-01-18 Takashi Sugiyama Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
DE3841873A1 (de) * 1988-12-13 1990-06-21 Gruenenthal Gmbh Neue serinprotease-inhibitor-proteine, diese enthaltende arzneimittel, dna-sequenzen, die fuer diese proteine codieren und verfahren zur herstellung dieser proteine, arzneimittel und dna-sequenzen
JP3961029B2 (ja) * 1992-06-24 2007-08-15 博 木戸 インフルエンザウィルス感染防止剤
US5334141A (en) * 1992-06-26 1994-08-02 Medrad, Inc. Extravasation detection system and apparatus
UA41338C2 (uk) * 1992-09-09 2001-09-17 Амген Інк. Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
US5376633A (en) * 1992-09-30 1994-12-27 Lezdey; John Method for deactivating viruses in blood component containers
US5633227A (en) * 1994-09-12 1997-05-27 Miles, Inc. Secretory leukocyte protease inhibitor as an inhibitor of tryptase

Also Published As

Publication number Publication date
RO113431B1 (ro) 1998-07-30
PL316444A1 (en) 1997-01-20
HU9602598D0 (en) 1996-11-28
WO1995025539A1 (en) 1995-09-28
CN1144488A (zh) 1997-03-05
KR970701561A (ko) 1997-04-12
NZ282488A (en) 1999-09-29
FI963753A7 (fi) 1996-09-20
AU1961195A (en) 1995-10-09
SK119896A3 (en) 1997-04-09
US5900401A (en) 1999-05-04
AU689559B2 (en) 1998-04-02
FI963753A0 (fi) 1996-09-20
EP0804930A4 (enExample) 1997-11-05
EP0804930A1 (en) 1997-11-05
CA2186111A1 (en) 1995-09-28
BR9507165A (pt) 1997-09-09
BG100835A (bg) 1997-06-30
HUT75660A (en) 1997-05-28
FI963753L (fi) 1996-09-20

Similar Documents

Publication Publication Date Title
Klenk et al. Host cell proteases controlling virus pathogenicity
CN101848719B (zh) 流感抑制组合物和方法
ES2606541T3 (es) Proteína CC10 humana recombinante para el tratamiento de la gripe
RU2711080C2 (ru) Комбинированный аэрозольный состав на основе ингибиторов протеаз и его получение
CZ265896A3 (en) Tryptase inhibitor, its use and pharmaceutical compositions containing thereof
US8222204B2 (en) Influenza inhibiting compositions and methods
Kido et al. The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses
MXPA96004207A (en) Novedous remedy for tractor pyrrato viral disease
JPWO1995025539A1 (ja) 新規気道部ウイルス疾患治療剤
WO2013066214A2 (ru) Фармацевтический аэрозольный состав ингибиторов протеаз и его получение
AU747723C (en) Prevention and/or treatment of allergic conditions
AU2008269081B2 (en) Influenza inhibiting compositions and methods
WO2022139764A2 (en) Development of an innovative inhalation formulation of nafamostat mesylate for the management of covid-19
EA040577B1 (ru) Комбинированный аэрозольный состав на основе ингибиторов протеаз и его получение
HK1142804B (en) Influenza inhibiting compositions and methods